Status:
COMPLETED
SLNB After Neoadjuvant Treatment in Node Positive Patients
Lead Sponsor:
Clinical Hospital Center Rijeka
Conditions:
Sentinel Lymph Node Biopsy
Locoregional Neoplasm Recurrence
Eligibility:
FEMALE
18-90 years
Brief Summary
From May 2016 till May 2018 all breast cancer patients with operable disease submitted to surgery after neoadjuvant treatment would be divided in four groups considering initially clinical axillary st...
Detailed Description
From May 2017 SLNB after neoadjuvant treatment was introduced in clinical practice for breast cancer patients presenting initially with involved axilla but shifted to clinically negative followed neoa...
Eligibility Criteria
Inclusion
- operable breast cancer submitted to neoadjuvant treatment in CHC Rijeka, followed by surgery in period from May 2016 till May 2018
Exclusion
- T4 stage
- inflammatory breast cancer
- M1 stage at the time of diagnose
- bilateral disease
- multicentric disease
- unavailable complete required data
Key Trial Info
Start Date :
May 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2019
Estimated Enrollment :
65 Patients enrolled
Trial Details
Trial ID
NCT03833960
Start Date
May 1 2016
End Date
June 1 2019
Last Update
December 19 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.